article · Egyptian Dental Journal /Egyptian Dental Journal
Background and objectives: Methotrexate (MTX) is a chemotherapeutic drug that is used in the treatment of many cancers and chronic inflammatory illnesses. Oral mucositis is a common side effect of MTX, which may lead to the discontinuation of chemotherapy. The study aimed to evaluate the possible protective effect of L-carnitine (LC) on the lingual mucosa of MTX-treated Albino rats. Material and Methods: Forty male albino rats were used in this experiment. The rats were divided into four experimental groups: Group 1 (negative control group), Group 2 (LC group), Group 3 (MTX group), and Group 4 (LC+MTX treated group). Rats were euthanized separately on day 14th. Tongue specimens were processed for hematoxylin & eosin staining and immunohistochemically prepared for TNF-α, COX-2, and Bax expression. The data was analyzed and expressed statistically by the one-way ANOVA test. Results: The negative control and LC groups showed normal histological structures of the lingual mucosa. The MTX group showed destruction in normal histological structure, while the group that took LC as a protective agent before MTX induction, showed a marked protection to the lingual mucosa from the destructive effect of MTX. Immunohistochemical results revealed mild to moderate immune reactivity to TNF-α, COX-2, and Bax in the negative control, LC, and LC+MTX groups, while a strong immune reactivity was observed in the MTX group (p<0.05). Conclusion: the current study proved that LC could act as a prophylactic agent before MTX treatment to prevent oral mucositis
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/edj.2024.265069.2902
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.